Diagnosis and control of hypertension in the elderly populations of Japan and the United States by Saito, Yasuhiko et al.
          International Journal of Population Studies 
 
International Journal of Population Studies | 2015, Volume 1, Issue 1 19 
RESEARCH ARTICLE 
Diagnosis and control of hypertension in 
the elderly populations of Japan and the 
United States 
Yasuhiko Saito1,2*, Shieva Davarian3, Atsuhiko Takahashi4, Edward Schneid-
er5 and Eileen M. Crimmins5 
1 University Research Center, Nihon University, 12-5 Gobancho, Chiyoda-ku, Tokyo, 102-8251, 
Japan 
2 School of Medicine, Nihon University, 30-1 Ooyaguchi Kamicho, Itabashi-ku, Tokyo, 
173-8610, Japan 
3 Orange County Social Services Agency, 500 N. State College Blvd., Orange, CA 92868, USA 
4 Department of Food and Nutrition, Advanced Course of Food and Nutrition, Junior College, 
Nihon University, 2-31-145 Bunkyo-cho, Mishima-shi, Shizuoka, 411-8555, Japan 
5 Davis School of Gerontology, University of Southern California, 3715 McClintock Ave. Los 
Angeles, CA 90089-0191, USA 
 
 
Abstract: The Japanese have the highest life expectancy in the world while the United States 
(U.S.) has relatively low life expectancy. Furthermore, the Americans have relatively poorer 
health compared to the Japanese. Examination of the treatment of specific conditions such as 
hypertension in these two countries may provide insights into how the health care system con-
tributes to the relative health in these two countries. In this study, we focus on the treatment of 
hypertension, as this is the most common condition requiring therapeutic interventions in se-
niors. This study examines hypertension diagnoses and controls in nationally representative 
samples of the older populations (68 years old or older) of Japan and the U.S. Data come from 
two nationally representative samples: the Nihon University Japanese Longitudinal Study of 
Aging (NUJLSOA) (n = 2,309) and the U.S. Health and Retirement (HRS) Study (n = 3,517). 
The overall prevalence of hypertension is higher in Japan than the U.S. Undiagnosed hyperten-
sion is about four times higher in Japan than in the U.S., while the control of blood pressure is 
more than four times higher in the U.S. than in Japan. Thus, the use of antihypertensive medi-
cation is much more frequent and more effective in the U.S. The medical care system seems to 
be more effective in controlling hypertension in the U.S. than in Japan. This may be due to the 
more aggressive diagnosis and treatment of hypertension in the U.S. 
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1. Introduction 
Studies conducted throughout the world have shown that prolonged hypertension leads to 
an increased risk of heart disease, stroke, kidney disease, and death (Benetos, Safar, Rud-
nichi et al., 1997; Coresh, Selvin, Steven et al., 2007; Digiovanna, 1999; Franklin, Larson, 
Khan et al., 2001; MacMahon, Peto, Cutler et al., 1990). Hypertension is one of the major 
controllable risk factors for poor health outcomes in old age. The number of older persons 
around the world using medication to lower blood pressure is growing. National differ-
ences in the effectiveness of hypertension diagnosis and treatment should relate to overall 
differences in population health and mortality. Japan is a world leader in life expectancy 
while the United States (US) lags behind Japan and many other advanced countries. These 
differences lead to questions about how Japan does so well in promoting long life and why 
the United States does so poorly. It has been suggested that Japan’s public health empha-
sizing on hypertension treatment has been an important factor in reducing stroke mortality 
and raising life expectancy (Murray, 2011). A detailed comparison of how hypertension 
diagnosis, treatment, and control differ between the two countries could provide some in-
sights into overall health differences. Furthermore, the diagnosis and the control of hyper-
tension among the elderly provide insights into the overall quality of national health care 
systems in caring for their elderly populations. 
Paradoxically, the incidence of hypertension in Japan is known to be relatively high; 
while that in the US is relatively low (Crimmins, Vasunilashorn, Kim et al., 2008; Marmot, 
Syme, Kagan et al., 1975; Crimmins, Garcia, and Kim, 2010). National levels of hyper-
tension may reflect differences in culture, social factors, epidemiological history, and 
health care policies as well differences in various dietary styles and genetic components at 
individual level. One important factor in national differences in the prevalence of high 
blood pressure is the use of antihypertensive medication which has resulted in lowered 
levels of hypertension among older persons in Japan and in the U.S. (Ikeda, Gakidou, Ha-
segawa et al., 2008). Antihypertensive medication usage increased earlier and remains 
higher in the U.S. than Japan (Crimmins, Garcia, Kim et al., 2010; Ikeda, Gakidou, Hase-
gawa et al., 2008). 
This study is unique in using individual level data from two nationally-representative 
studies to examine hypertension among those 68 years of age and older in the U.S. and 
Japan. Many studies of hypertension are based on local or regional samples and are not 
representative of the entire country. In addition, this study utilizes both self-report and 
measured blood pressure so that a more complete picture of hypertension in the elderly 
population is provided. This results from the comparisons not only of measured high blood 
pressure but also of undiagnosed, controlled and uncontrolled high blood pressure. This is 
possible because measured blood pressure has recently been added to the U.S. Health and 
Retirement Study (HRS) and the Nihon University Japanese Longitudinal Study of Aging 
(NUJLSOA), providing an opportunity for a comparative analysis between national sam-
ples of these two countries. These longitudinal studies already included self-reports of 
hypertension and use of antihypertensives. This is the first cross-national comparison us-
ing measured blood pressure indicators based on individual level data for these two coun-
tries. This allows us to examine the associations between demographic factors and the 
prevalence, diagnosis, and control of hypertension in the two countries. 
The questions that will be addressed in this paper are: (i) how do levels of overall 
hypertension, and diagnosed and undiagnosed hypertension differ among older persons in 
Japan and the U.S.; (ii) how does antihypertensive medication use and control of hyper-
tension differ by country; and (iii) how are these measures of hypertension and control of 
hypertension associated with measured systolic blood pressure. 
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2. Data and Methods 
2.1 Data Sources 
This study used data from the 2006 (fourth wave) of the Nihon University Japanese Lon-
gitudinal Study of Aging (NUJLSOA), and data from the 2006 Health and Retirement 
Study (HRS). The NUJLSOA is a nationally representative sample of the Japanese popula-
tion aged 65 and older at baseline collected by researchers at Nihon University. The fourth 
wave contains data from participants aged 68 years and older. Complete information on 
the design and methods of the study can be found on the website of the survey (Nihon 
University Japanese Longitudinal Study of Aging). 
The fourth wave of the survey includes 3,403 participants, of whom approximately 68% 
participated in the collection of blood pressure measurements (n = 2,330). Our sample 
consists of the 2,309 cases for whom both measured and self-reports of hypertension are 
available. The average age of the sample was 76.1 years, of whom 54.9% were female. 
The participants who were missing on measured blood pressure differed from those in-
cluded in the analysis in that they were older (1.01 years, p<0.01) and had lower rates of 
antihypertensive medication usage (9%, p<0.01). 
The Health and Retirement Study (HRS) surveys more than 22,000 Americans over the 
age of 50 every two years. Data for the eighth wave of HRS used in this study were col-
lected in 2006, the same time as the fourth wave of NUJSLOA. A detailed description of 
the study is provided at a website hosted by the University of Michigan. Half of the HRS 
2006 sample was randomly chosen to participate in an enhanced face-to-face interview 
where blood pressure was measured. Respondents who used a proxy or who resided in a 
nursing home did not have measured blood pressure. The total number of the respondents 
who participated in the enhanced face-to-face interviews and who were 68 years of age 
and over was 4,730; of these 1,137 did not have blood pressure measurements and were 
not included in this study. The sample of 3,517 with information on both measured and 
self-reported hypertension used for this study was quite similar in composition to the Jap-
anese sample and included 58.8% females and had an average age of 76.7. Relative to 
those included in the analysis, the participants who were missing on blood pressure mea-
surements were older (3.21 years, p<0.01). There was no significant difference in antihy-
pertensive medication usage (p = 0.97) between those included in the study and those who 
were missing on blood pressure measurements. 
2.2 Measurements 
Protocols for blood pressure recordings were almost identical between HRS and NUJL-
SOA except that the measurements were taken during the midst of an interview for HRS 
and at the end of an interview for NUJLSOA. The blood pressure monitor used in NUJL-
SOA was OMRON HEM-762 (OMRON, Kyoto, Japan) and for HRS it was OMRON 
HEM-780N (OMRON, Kyoto, Japan); the device has been validated in independent stu-
dies (Shirasaki, Asou and Takahashi, 2007). Blood pressure was measured three times with 
approximately one minute between each measurement and the average of the available 
readings was used for analysis. If fewer than three readings were recorded, then the aver-
age of those readings was included. The participant was generally in a seated position and 
the recording was generally performed on the left arm for both surveys. 
Measured hypertension is a binary variable that indicates a person had an average sys-
tolic measurement of 140 mmHg or greater and/or a diastolic measurement of 90 mmHg 
or greater. Use of antihypertensive medication was reported in the same way in both sur-
veys. Respondents who responded affirmatively to ever having been diagnosed or having 
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experienced hypertension were then asked if they used medication for the condition. 
Overall hypertension is indicated by either having measured hypertension or using medi-
cation. Table 1 presents descriptive measures on the sample and for the hypertension 
measures. 
By utilizing measured hypertension and diagnosed hypertension, we are able to divide 
the total population into four hypertension categories: healthy, undiagnosed hypertension, 
controlled hypertension, and uncontrolled hypertension. Healthy was defined as not having 
measured hypertension and reporting that one has never been diagnosed with or expe-
rienced hypertension. Undiagnosed hypertension was defined as having measured hyper-
tension but reporting that one has never been diagnosed with or experienced hypertension. 
Uncontrolled hypertension was defined as having measured hypertension and reporting 
hypertension. Controlled hypertension was defined as having been diagnosed with or ex-
periencing hypertension and having measured systolic blood pressure of less than 140 
mmHg and diastolic blood pressure of less than 90 mmHg. 
2.3 Statistical Methods 
All analyses were weighted and conducted on Statistical Analysis System (SAS) 9·2 (SAS 
Institute Inc. Cary, NC). To account for missing data on measured blood pressure, an ad-
justed weight was created for NUJLSOA by multiplying the normalized weight of the 
sample which accounted for the lack of survey response and differential selection by age 
by the inverse of the predicted probability that each participant would have a blood pres-
sure measurement. The predicted probability was based on age, sex, and level of education. 
It was used in all analyses. For the HRS, sample weights which accounted for survey 
non-response, nonresponse to the blood pressure measurement, and initial proability of 
selection were provided by the survey and were used for all analyses. 
3. Results 
3.1 Descriptive Results 
Table 1 indicates that Japanese over age 68 are almost twice as likely as their American 
counterparts to be measured as hypertensive (74.3% versus 39.5%). By contrast, Japanese 
persons are significantly less likely to report that they have been diagnosed with hyperten-
sion (37.9% in Japan vs 64.1% in the U.S.). Older Japanese are also much less likely to 
use antihypertensive medication than their American counterparts (36.0% vs 59.7%). The 
overall prevalence of hypertension, which includes either measured hypertension or use of 
medication, is also significantly higher in Japan than in the U.S. (82.0% vs 74.1%). 
We then integrated self-reports and measured levels to examine the prevalence of diag-
nosis and control. We find that there are much higher rates of undiagnosed hypertension in 
Japan (44.3%) than in the U.S. (11.9%) for this older age group (Table 2). In addition, the 
 
Table 1. Measured, self-reported hypertension, use of hypertensives, overall hypertension by country 
 Japan  Percent of total sample 
United States 
Percent of total sample 
Measured Hypertension 74.3  (72.5–76.1) 39.5  (37.8–41.1) 
Self-Reported Hypertension 37.9  (35.3–40.0) 64.1  (62.5–65.7) 
Use of Antihypertensives 36.0  (34.0–38.0) 59.7  (58.1–61.4) 
Overall Hypertension 82.0  (80.4–83.6) 74.1  (72.6–75.5) 
n 2309 3517 
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Table 2. Hypertensive states: healthy, undiagnosed, controlled, uncontrolled by country 
 Japan Percent 
United States 
Percent 
Healthy 17.8  (16.1–19.3) 24.0  (22.6–25.4) 
Undiagnosed 44.3  (42.2–46.4) 11.9  (10.8–12.9) 
Controlled 8.0  (6.8–9.1) 36.5  (34.9–38.1) 
Uncontrolled 29.9  (28.1–31.9) 27.6  (26.1–29.5) 
Total 100.0 100.0 
n 2309 3517 
 
Japanese also experience much lower levels of controlled hypertension (8.0%) compared 
to the U.S. (36.5%). However, uncontrolled blood pressure is not significantly different in 
the U.S. (27.6%) and Japan (29.9%). The proportion healthy (without any hypertension) is 
somewhat higher in the U.S. (24.0% vs 17.8%). 
3.2 Blood Pressure Values in the U.S. and Japan  
In order to increase our understanding of the reasons for the large differences reported 
above, we examined the distribution of systolic and diastolic blood pressure levels in the 
total samples (Figure 1) and systolic pressure among those who are classified as having no 
hypertension, undiagnosed hypertension, controlled, and those with uncontrolled hyper-
tension who are taking medications (Figure 2). This detail indicates the sources of the dif-
ferences in hypertension as well as providing some idea of how much blood pressure 
needs to be changed to achieve control. The modes of the distributions of systolic and di-
astolic blood pressure for the Japanese sample are 20 and 10 percentage points higher than 
those for the American sample (Figure 1). The Japanese group also has a higher level of 
systolic blood pressure in each of the subcategories (Figure 2). In those with no hyperten-
sion, 53% of Japanese have systolic blood pressures between 130 and 139, more than 
twice as many as that of Americans (24%). This group is considered pre-hypertensive and 
at high risk of developing hypertension. Many clinicians would consider recommending 
lifestyle adjustments to these pre-hypertensive individuals to lower blood pressure. Among 
those who have uncontrolled systolic hypertension, more Japanese than Americans have a 
level of blood pressure higher than 160 mmHg. Among those with controlled systolic 
hypertension the levels of blood pressure are also considerably higher among Japanese, 
with 64% of Japanese in the 130–140 range, and just 31% of Americans in that category. 
This indicates that treating blood pressure is much less effective in controlling blood pres-
sure in Japan. This could be the result of differences in aggressiveness of treatment,  
 
 
 
Figure 1. Distribution of (A) systolic blood pressure (SBP) and (B) diastolic blood pressure (DBP) measurement: Japan and U.S. 
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Figure 2. Distribution of measured systolic blood pressure (SBP) by hypertensive state. 
 
different drug regimens (Singer, Izhar and Black, 2002), drug titration, patient compliance 
with medication (Cushman and Basile, 2006), physician compliance with recommended 
blood pressure levels (Oliveria, Lapuerta and McCarthy et al., 2002), or resistance of 
hypertension to treatment (Singer, Izhar and Black, 2002). 
4. Discussion 
This study examined differences in hypertensive states and the levels of blood pressure 
among older persons in Japan and the U.S. Older Japanese persons have more hyperten-
sion arising from higher levels of both systolic and diastolic blood pressure. We find Japan 
has more undiagnosed hypertension and less controlled hypertension among those who 
take medications. The lower level of diagnosis, treatment, and effective control of blood 
pressure in Japan is somewhat surprising given the impressively high life expectancy and 
universal health care. However, previous studies in Japan had indicated that 80% to 90% 
of hypertensives aged 30 to 40 were not treated (Ministry of Health, Labor and Welfare, 
2009). Other studies in Japan have reported a lack of control for about half of those taking 
antihypertensive medication (Hozawa, Ohkubo, Kikuya et al., 2002; Ohkubo, Obara, and 
Funahashi, 2004). There are two sources of published data on measured hypertension in 
the Japanese population 70 years of age and older. Both of these indicate lower levels of 
measured hypertension than found here. The Fifth Japanese National Survey of Circulato-
ry Disorders in 2000 reports 67% of those aged 70 and older have measured hypertension 
(Ministry of Health, Labor and Welfare, 2009); in the National Health and Nutrition Sur-
vey (NHNS) for 2006 the figure is 55% (Ministry of Health, Labor and Welfare, 2009) ; we 
report 74% among those aged over 68. We should note that in the NUJLSOA, blood pres-
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sure was measured as part of a home interview; while both the survey of circulatory dis-
orders and the NHNS required measurement at a site away from home. The need to leave 
home in order to be included in a study is one cause of underrepresentation of the oldest 
and most frail; only 7.0% of the NHNS sample was 85 years or older and only 1.4% was 
90 years or older, compared to 11.9% and 3.3% in the NUJLSOA. On the other hand, 
younger people are more represented in the NHNS, 18.1% of the sample persons aged 68 
and older is 68 and 69 years of age, whereas only 12.6 % of the NUJLSOA is in these two 
ages. People who are sicker and frailer are also less represented in the NHNS.  The pro-
portion of the sample aged 68 and older with a lot of difficulty in performing activities of 
daily living is almost twice as high as (1.81 times) in the NUJLSOA. Because the NUJL-
SOA is an ongoing longitudinal study, sicker people are more likely to continue to partici-
pate than if they were being newly recruited to a study.  In addition, measurement at 
home, as is done in the NUJLSOA, could raise measured blood pressure because of a “re-
verse white coat” syndrome. Blood pressure measurement at home has been reported to 
exceed measurement in clinics in Japan (Liu, Roman, Pini et al., 1999; Selenta, Hogan and 
Linden, 2000; Wing, Brown and Beilin, 2002). Comparison of home versus clinic mea-
surement in one Japanese study among hypertensives indicated an increase of 12% in 
those measured as uncontrolled at home (Obara, Ohkubo, Funahashi et al., 2005). Because 
both the Japanese study and the U.S. study were conducted at home with similar instru-
ments and because both are weighted to represent the population aged 68 and older, they 
should be comparable in measured hypertension; however, the differential timing of the 
blood pressure measurement in the two studies could have potentially resulted in a relative 
increase in Japanese blood pressure.  
The lack of hypertension diagnosis and lack of hypertension control is unlikely to be 
explained by a lack of contact with the medical system in either Japan or the U.S. Japan is 
a country where the population has very high medical contacts. The average reported 
number of physician visits in the year prior to survey for this Japanese sample was 20.9 
and this does not vary much by hypertensive state. Even the undiagnosed and the uncon-
trolled hypertensives average 21 and 20 doctor visits in the past year, respectively. Older 
Americans in the HRS reported many fewer doctor visits, e.g., who were over age 68 re-
ported an average of 5.5 visits in the year prior to survey, those with undiagnosed hyper-
tension having 3.5 visits and those with uncontrolled hypertension having 5.3 visits. There 
are few people in both countries who reported not seeing a physician at all in the year prior 
to survey. In Japan, no one reported not having had a doctor’s visit in the year prior to 
survey, whereas this was true of only 7.1% of the Americans. However, this value was 
higher among Americans with undiagnosed hypertension, 17.4%. Thus, it does not appear 
that medical exposure is responsible for the lack of hypertension diagnosis or control in 
Japan; instead it could be a factor in the lack of diagnosis in the U.S. 
The high frequency of medical visits in Japan is in part due to the practice of providing 
prescriptions for short time periods. In 2006, most drugs could only be prescribed for a 
thirty-day period and selected drugs for only a fourteen-day period in Japan. Renewing a 
prescription required another doctor visit. By contrast, prescriptions can be renewed for 3 
months or even longer time periods in the U.S. and renewal can also be done by phone. 
This practice of required physician visits could also result in patients in Japan being more 
likely to be non-compliant with anti-hypertensive medication regimens.   
An explanation for why more people might remain undiagnosed in Japan than the U.S. 
is that some specialists in Japan do not routinely measure blood pressure as part of a doc-
tor visit. For instance, departments in hospitals for treatment of eyes, ears, and orthopedics, 
do not routinely perform blood pressure measurement in Japan. A second potential expla-
nation for differences in hypertension control is the difference in the pattern of prescribed 
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antihypertensives. The improvement of blood pressure control in the U.S. in recent years 
(Crimmins, Garcia, and Kim, 2010; Cutler, Sorlie, Wolz et al., 2008; Hajjar and Kotchen, 
2003) is generally credited to the increasing use of polytherapy (concomitant prescription 
of multiple classes of antihypertensive medications). In 2004, approximately 60% of anti-
hypertension drug treatment regimens involved multiple drugs (Ma, Lee, and Stafford, 
2006) . In 2002 a large study of Japanese treatment of hypertensives found that combina-
tion therapy occurred in only 35.3% of patients (Mori, Ukai, Yamamoto et al., 2006). 
Another possible explanation for the observed differences could be goal-oriented man-
agement of hypertension which is more common in the U.S. while a fixed drug treatment 
algorithm is more common in Japan (Cushman and Basile, 2006) . 
All of these factors point to interventions in clinical practice to reach optimal blood 
pressure control. Regular monitoring, providing diagnoses, prescribing medications so that 
they can be easily obtained, and titration of drug regimens are all crucial to control of 
hypertension. However, underlying differences in the level of blood pressure between so-
cieties may still have an effect on outcomes. 
The results of our study reveal the complexities of looking at international differences 
in health. Given their increased life expectancy and universal health care access, one 
would have expected the Japanese diagnosis and control of hypertension to be superior to 
that in the U.S. We find that the U.S. is relatively effective in diagnosing and treating 
hypertension. However, hypertensive treatment may not reflect other medical treatments. 
Lastly, hypertensive related mortality is primarily linked to stroke, which is not the leading 
or even second leading cause of death in both countries and may therefore not contribute 
as much as cancer or cardiovascular mortality to overall life expectancy (Glei, Mesle, and 
Vallin, 2010). Mortality from stroke has dropped markedly in Japan in recent years; al-
though it remains somewhat higher in Japanese men and women than in Americans. 
We should note some limitations of our study. We were only able to compare national 
samples for 2006 and hypertensive state and the use of medications are changing rapidly in 
both countries so that future research should examine changes after 2006. In addition we 
do not consider all the determinants of hypertensive state in this analysis. For instance, 
there are life style factors that may be related to hypertension such as obesity and smoking 
(Davarian, Crimmins, Takahashi et al., 2013). Further investigation of these in compara-
tive analyses may provide greater insights into the root of these differences. 
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